Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J0637 Caspofungin acetate

J Codes (Drugs)

Also known as: caspofungin, Cancidas, echinocandin

Caspofungin acetate injection, an echinocandin antifungal agent for treatment of invasive Candida and Aspergillus infections.

In Plain Language

fungal infection treatment injection; hospital-acquired fungus medication

Clinical Context

Echinocandin fungal agent inhibiting cell wall synthesis, used for invasive candidiasis, esophageal candidiasis, and invasive aspergillosis. Preferred in neutropenic and critically ill patients.

RVU Information

CPT J0637 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

infectious diseasecritical carehematology/oncology

Frequently Asked Questions

What is CPT code J0637?

CPT J0637 (Caspofungin acetate) is a J Codes (Drugs) code. Caspofungin acetate injection, an echinocandin antifungal agent for treatment of invasive Candida and Aspergillus infections.

How is J0637 administered?

CPT J0637 is administered by a healthcare provider, typically via injection or infusion. Echinocandin fungal agent inhibiting cell wall synthesis, used for invasive candidiasis, esophageal candidiasis, and invasive aspergillosis. Preferred in neutropenic and critically ill patients. It is used by infectious disease, critical care, hematology/oncology.

When is CPT J0637 used?

Echinocandin fungal agent inhibiting cell wall synthesis, used for invasive candidiasis, esophageal candidiasis, and invasive aspergillosis. Preferred in neutropenic and critically ill patients.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.